Recent Company News

• 09:52 AM ET Aug 17, 2026
  

  StreetAccount Summary - Private company transactions for the week ended 15-Aug

• 07:40 AM ET Aug 14, 2026
  

  Vera Therapeutics trading higher; FDA posts integrated review of Trutakna ($28.89, 0.00)

• 07:07 AM ET Aug 10, 2026
  

  MoonLake reports topline results from phase 3 IZAR-1 trial of sonelokimab in psoriatic arthritis ($18.26, 0.00)

• 11:05 AM ET Aug 06, 2026
  

  Transcript Intelligence: Merck KGaA Q2 Earnings Guidance

• 11:05 AM ET Aug 06, 2026
  

  Transcript Intelligence: Merck KGaA Q2 Earnings Themes

• 11:05 AM ET Aug 06, 2026
  

  Transcript Intelligence: Merck KGaA Q2 Earnings Q&A

• 06:52 AM ET Aug 06, 2026
  

  Media, telecom, banks, energy and utilities outperform; industrials, travel and tech the main laggards:

• 03:56 AM ET Aug 06, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (91 total)

• 03:27 AM ET Aug 06, 2026
  

  Quick Take - Merck shares are trading +0.7% higher after reporting Q2 earnings ahead of expectations and once again raising FY26 guidance (€145.00, 0.00)

• 02:58 AM ET Aug 06, 2026
  

  StreetAccount Summary - European pre-market trading update